Aspira Women's Health Inc.

NASDAQ:AWH

0.772 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 9.1548.1846.8124.6514.5383.0533.1212.6422.1772.5212.5662.0941.9231.17500.1240.04418.21527.24640.18158.37239.319.0498.9355.012.933
Cost of Revenue 3.8923.8653.753.4153.3433.1422.9142.6982.3091.230.170.1310.1290.08800.0240.0289.33813.69315.07527.84512.7586.614-6.813-0.2351.068
Gross Profit 5.2624.3193.0621.2361.195-0.0890.207-0.056-0.1321.2912.3961.9631.7941.08700.10.0168.87713.55325.10630.52726.54212.43515.7485.2451.865
Gross Profit Ratio 0.5750.5280.450.2660.263-0.0290.066-0.021-0.0610.5120.9340.9370.9330.92500.8060.3640.4870.4970.6250.5230.6750.6531.7631.0470.636
Reseach & Development Expenses 4.0355.9535.3142.1041.0180.550.8372.1723.7514.6672.5952.2165.3873.8482.3465.2898.21311.47413.19619.26824.9220.75412.8957.4753.1394.733
General & Administrative Expenses 12.26716.18313.2578.275.815.0525.5435.9285.5335.9424.1844.5088.5098.9842.5627.30913.03323.22934.86640.51240.65835.32927.32120.3237.7884.762
Selling & Marketing Expenses 7.81214.94817.0868.8439.6455.6424.2686.7989.8339.8934.484.6535.5392.8570.4552.0192.17512.56818.00926.37624.82720.32114.3019.00100
SG&A 20.07931.13130.34317.11315.45510.6949.81112.72615.36615.8358.6649.16114.04811.8413.0179.32813.03323.22934.86640.51240.65835.32927.32120.3237.7884.762
Other Expenses 00.1060.9810.066-0.018-0.016-0.0140.0140.106-0.0380.021-0.1820000-1.61-6.929000.8290.8291.6510.6112.3080.279
Operating Expenses 24.11437.08435.65719.21716.47311.24410.64814.89819.11720.50211.25911.37719.43515.6895.36314.61719.63627.77448.06259.7866.40756.91241.86638.40913.2359.774
Operating Income -18.852-32.765-32.595-17.981-15.278-11.333-10.441-14.954-19.249-19.211-8.863-9.414-17.641-14.602-5.363-14.517-19.62-18.897-34.509-34.674-35.88-30.37-29.431-22.661-7.99-7.909
Operating Income Ratio -2.059-4.004-4.785-3.866-3.367-3.712-3.345-5.66-8.842-7.62-3.454-4.496-9.174-12.4270-117.073-445.909-1.037-1.267-0.863-0.615-0.773-1.545-2.536-1.595-2.697
Total Other Income Expenses Net 2.1621.2530.9330.0760.041-0.038-0.056-0.0140.1340.0020.0442.268-0.149-4.432-16.674-3.8530.111-3.017-1.871-2.1450.541.3593.762-24.871-0.1220.17
Income Before Tax -16.69-27.17-31.662-17.905-15.237-11.371-10.497-14.968-19.115-19.209-8.819-7.146-17.79-19.034-22.037-18.37-21.119-21.914-36.38-36.819-35.34-29.011-25.669-47.532-8.112-7.739
Income Before Tax Ratio -1.823-3.32-4.648-3.85-3.358-3.725-3.363-5.665-8.78-7.62-3.437-3.413-9.251-16.1990-148.145-479.977-1.203-1.335-0.916-0.605-0.738-1.348-5.32-1.619-2.639
Income Tax Expense 0-5.5950.048-0.275-0.392-0.038-0.744-0.695-0.319-0.181-0.051-0.0620.3960.4910.011-0.040.1630.1520.0070.1091.4070.0610.143-2.3570.0560.143
Net Income -16.69-21.575-31.71-17.63-14.845-11.371-10.497-14.968-19.115-19.209-8.819-7.146-17.79-19.034-22.048-18.33-21.282-22.066-35.433-19.841-36.747-29.072-25.812-20.304-8.046-8.052
Net Income Ratio -1.823-2.636-4.655-3.791-3.271-3.725-3.363-5.665-8.78-7.62-3.437-3.413-9.251-16.1990-147.823-483.682-1.211-1.3-0.494-0.63-0.74-1.355-2.272-1.606-2.745
EPS -1.81-41.66-4.28-2.63-2.57-2.43-2.77-4.35-6.15-7.99-6.32-7.2-18.73-27.44-49.64-43.08-66.99-90.77-164.44-101.77-195.78-161.72-146.04-261.76-188.67-243.02
EPS Diluted -1.81-41.66-4.28-2.63-2.57-2.43-2.77-4.3-6.08-7.99-6.32-7.14-18.73-27.44-49.64-43.08-66.99-90.77-164.44-101.77-195.78-161.72-146.04-261.76-188.67-243.02
EBITDA -16.491-30.874-32.293-17.716-14.945-10.658-9.655-14.231-18.958-19.07-8.791-6.854-17.317-18.429-20.011-15.407-17.636-15.578-28.138-26.869-29.558-26.149-22.061-12.05-5.682-6.868
EBITDA Ratio -1.802-4.672-4.741-3.866-3.367-3.712-3.345-5.66-8.842-7.62-3.437-4.569-9.1-12.2960-106.371-450.182-1.061-1.006-0.653-0.521-0.665-1.094-1.336-1.11-2.4